Skip to main content
PLOS One logoLink to PLOS One
. 2022 Oct 14;17(10):e0266291. doi: 10.1371/journal.pone.0266291

Determinants of anthroponotic cutaneous leishmaniasis by case-control study in Morocco

Mounia Amane 1, Mohamed Echchakery 1,2, Mohamed Daoudi 1, Mohamed Hafidi 1, Samia Boussaa 1,3,*
Editor: Albert Schriefer4
PMCID: PMC9565455  PMID: 36240203

Abstract

Leishmaniasis is endemic in Morocco where both cutaneous and visceral forms coexist. To date, anthroponotic cutaneous leishmaniasis (ACL) determinants remain poorly investigated in Morocco. However, the disease risk factors identification is vital to determine the specific preventive process. In this aim, a case-control study was conducted in the main active ACL foci in central Morocco. Epidemiological data were extracted from bulletins, registers and annual reports of the regional direction of Health offices. The socioeconomic and environmental data were collected from epidemiological surveys, completed by a questionnaire intended for accessible positive population and control people selected from the cases’ entourage. The study included 258 cases and 395 controls. Our results showed that many socioeconomic factors were associated with ACL in Morocco such as the rural habitation (OR = 4.163; 95% CI: 2.91–5.96), movement to endemic area (OR = 4.53; 95% CI: 3.03–6.77), provenance from leishmaniasis foci (in Essaouira focus OR = 5.34; 95% CI: 1.19–24.03) and poverty. In addition, environmental factors like proximity of vegetation (OR = 2.45; 95% CI: 1.14–5.25), poor domestic hygiene, particularly the absence of sewage system/waste management (OR = 1.63; 95% CI: 1.35–1.96), and presence of animals (OR = 2.67; 95% CI: 1.14–5.25) increase the risk of ACL in Morocco. Except for Matrimonial status (married people, OR = 4.11; 95% CI: 1.80–9.41), there is however no significant association of the disease with the other socio-demographic factors in the study area (p>0.05). These several risk factors must be taken in consideration to prevent this disease through multidisciplinary collaboration and community participation.

Introduction

Leishmaniasis is endemic in Morocco where both cutaneous and visceral forms coexist. Human visceral leishmaniasis is caused by Leishmania (L) infantum MON-1, while cutaneous leishmaniasis is caused by three Leishmania species. Leishmania major MON-1 is responsible for the endemic zoonotic cutaneous form in the southeastern region; L. infantum MON-24 is responsible for sporadic cutaneous cases mainly in the northern region; and L. tropica causes anthroponotic cutaneous leishmaniasis (ACL) primarily in central Morocco [1, 2].

According to many authors, epidemiological status of visceral leishmaniasis by L. infantum and cutaneous leishmaniasis by L. major remain comparatively stable in Morocco in terms of geographical distribution [13]; while cutaneous leishmaniasis by L. tropica continues to appear in non-endemic regions [4, 5]. Leishmania tropica notably has the largest geographic distribution in Morocco [6] and it is an etiological cause of human cutaneous leishmaniasis in rural as well as in urban and peri-urban area of Morocco [3, 5]. In addition, Moroccan strains of L. tropica show highest genetic diversity with eight zymodems: MON-102, MON-107, MON-109, MON-112, MON-113, MON-122, MON-123 and MON-273 that were reported from human cases, dogs, and the sand fly vector [5, 7].

Phlebotomus sergenti is the only proven vector of L. tropica in Morocco [6, 7] where it is widespread [8]. The disease is often described as being anthroponotic [7]; however, L. tropica was isolated several times from dogs in northern and central Morocco [911] and from rodents in central Morocco [12]. Over a period of ten years (2008–2017) 54,838 cases of all forms of leishmaniasis have been reported in Morocco, of which ACL represents 43.3% of all recorded cases. It is characterized by an increasingly widespread dynamic in peri-urban and urban areas with rural character [13].

To date, local ACL determinants remain poorly investigated in Morocco. However, the disease risk factors identification is vital to determine specific preventive methods. In fact, several risk factors have been identified in the spread of leishmaniasis, namely physical and biotic factors, ecosystem diversity, socioeconomic conditions, environmental factors, deforestation due to urbanization, domestic animals and standard of living [14, 15]. Indeed, multiple studies have addressed the effect of seasonality [16], climatic factors [14, 17, 18] and the effect of urbanization on the distribution of leishmaniasis vectors [1921]. However, in Morocco, studies that address the association between leishmaniasis and human factors are absent. The present study aims to determine the different factors associated with the distribution of ACL in Morocco. Thus, a case-control study was conducted in central Morocco where L. tropica ACL still a big health problem.

Materials and methods

1. Study area

a. Geographical and environmental conditions

The Marrakech-Safi region lies in central west Morocco (Fig 1) and contains one Prefecture (Marrakech) and seven Provinces (Al Haouz, Chichaoua, El Kelâa Des Sraghna, Essaouira, Rhamna, Safi and Youssoufia), with a total area of 39,167 km2 [22]. The total population of Marrakech-Safi region is 4,520,569 inhabitants, with 43% urban and 57% rural populations, according to High Planning Commission [23].

Fig 1. Presentation of study area [24].

Fig 1

The 0–500 meters elevation class represents 56.5% of the total area of the Region. Mountain Zone is the mountains of Al Haouz, characterized by high and medium altitudes which rise in the High Atlas range to 4,165 m (Toubkal Mount) [24].

The climate of the region is characterized by apparent variability (average summer temperature of the maxima 37.7C° and minima 4.9C°) with low and irregular rainfall. The rain varies from 800mm in the mountains to 190mm in the plain, influenced by the Atlantic Ocean and the high altitudes of the High Atlas. The arid and semi-arid climates are consistent throughout the region; the sub-humidity appears only in the High Atlas between 1,500 and 2,000 meters. Almost half of the regional area has rainfall below 300 mm/year [22]. The forests of the Marrakech-Safi region cover an area of 721,876 hectares, representing 22.6% of the national total, including nearly 65,120 hectares of artificial forest and fruit plantations in DRS (Defense and Restoration of Soil). The rate of forest cover in mountain and forest areas is around 43%, with an average of 22% for the entire region. The mountainous character of the Atlas range gives it a pastoral and forestry vocation [23].

b. Epidemiological status

Marrakech-Safi region is one of the regions most affected by L. tropica cutaneous leishmaniasis (Fig 2). Provinces of Chichaoua, Essaouira, and Al Haouz are the main endemic foci of ACL by L. tropica in Morocco. In 2017 they reached respectively 471, 77 and 65 new cases according to Moroccan Ministry of Health [13].

Fig 2. Distribution of ACL cases in Morocco by endemic region between 2013 and 2017 according to data reported by National Ministry of Health [13].

Fig 2

2. Study design and population

An unmatched case-control study was conducted to explore the risk factors associated with ACL by L. tropica at socio-demographic, socioeconomic and environmental levels. Case population was recruited based on the ACL incidence data, provided by the Epidemiology and Parasitic Disease office of the Regional Health Direction. All patients reported positive for ACL between 2018 and 2020 were eligible if they had resided in the target area for at least one year. The control population was selected from the declared cases’ entourage by domicile visit.

The sample size was estimated in OpenEpi (version 3.01) [25], considering the following parameters: Type I error (α) of 0.05 (Using a 95% confidence interval), normal power approximation with continuity correction (1-β) of 90%, minimum detectable OR of 2.00 and 1:1.5 case to control ratio. The ‘Fleiss Method with Continuity Correction’ was used [26].

Thus, 232 cases and 356 controls were calculated as the minimum number of participants required for this study. However, to account for non-participation and incomplete questionnaires, this number was increased adding 10%. Finally, 258 cases and 395 controls were selected randomly to participate in the present study.

3. Variable definition

In the present study, a confirmed case of ACL is a person that presents clinical signs (skin or mucosal lesions) with parasitological confirmation of the diagnosis (positive smear or culture) [27] registered between 2018 and 2020 in Marrakech Safi region.

Control individual is a person without clinical signs, with negative rapid test, negative smear or culture. Controls are recruited from the reports of epidemiological surveys conducted by Health personnel around confirmed cases recorded between 2018 and 2020.

4. Data collection

Epidemiological data were extracted from the bulletins, registers and annual reports of the Regional Direction of Health offices. The epidemiological surveys were completed by a structured questionnaire intended for accessible positive population as well as for the control people.

The questionnaire form was designed for an exploratory approach and it covered three sections: socio-demographic (Gender, Age, Matrimonial status, Level of study, Knowledge about leishmaniasis), socio-economic (Number of children per family, Person per household, Provinces, Monthly income, Zone, Travel to endemic area, Profession) and environmental data (Sewage system/waste management, Toilet/Waste water management, Mosquito nets, Vegetation, Farm animals, Companion animals). The categorization was based on previous studies exploring the factors of leishmaniasis in all its forms [28]. The questionnaire form was validated first by conducting a pre-testing on a small group of local population not included in the final participant list.

5. Data analysis

The data were analyzed by using SPSS statistical software (version 21). The association between the dependent and independent variables was measured using the Chi-Square Test (S1 Data). Risk factor data were analyzed by binary logistic regression (S1 Data). Odd Ratio was calculated with a 95% confidence interval for each variable. All statistical tests were performed at a significance level of 0.05 (S1 Data).

6. Ethical statement

This study was part of a project approved by the Ethical Hospital-University Committee (Faculty of Medicine and Pharmacy, University of Cadi Ayyad, Marrakech, Morocco) with approval number 020/2016, to carry out an epidemiological study on leishmaniasis in the Marrakech-Safi region. In addition, the official authorization to examine files and data collection was obtained from the Regional Direction of the Moroccan Ministry of Health and Social Protection (Ref.1080/2020). Informed verbal consent was taken from all participants (adults and a parents or guardians of minor participants) before enrolment in the study.

Results

A total of 653 participants were recruited in our study. 258 (39%) were confirmed cases of ACL caused by L. tropica recorded in the region between 2018 and 2020, while 395 (61%) were the correspondent controls (S1 Data).

1. Socio-demographic factors

When considering socio-demographic characteristics (Table 1, S1 Data), cases and controls groups were largely represented by the age categories (from 0 to more than 40 years). Females are more affected by the disease (53.49%) and the chances of getting ACL are slightly higher in women (OR = 1.16, 95% CI: 0.84–1.60). The marital status seemed to be associated significantly with ACL (p = 0.005). 51.2% of the cases are single while 67.6% of the controls are married, thus to be married is a risk factor for ACL (OR = 4.11, 95% CI: 1.80–9.41) in the study area.

Table 1. Socio-demographic determinants associated with ACL, in the Marrakech-Safi region, Morocco between 2018 and 2020.

Variables Modalities Case Control OR CI for Exp (B) 95% P-value
N (%) N (%) Lower Upper
Gender Male Female 120(46.51) 175(49.72) Ref Ref Ref 0.242
38(53.49) 177(50.28) 1.16 0.84 1.60
Age (years) 0–5 43(16.67) 49(13.92) Ref Ref Ref
6–19 71(27.52) 96(27.28) 1.19 0.71 1.98 0.650
20–40 87(33.72) 116(32.95) 1.19 0.72 1.94
> 40 57(22.09) 91(25.85) 1.43 0.84 2.42
Matrimonial status Single 62(51.2) 9(26.5) Ref Ref Ref
Married 52(43) 23(67.6) 4.11 1.80 9.41
Widowed 6(4.9) 1(2.9) 3.45 0.73 16.27 0.005
Divorced 1(0.9) 1(2.9) 6.89 0.40 120.13
Level of study Literary 31(23.7) 9(18) Ref Ref Ref 0.261
Primary 55(42) 27(54) 1.69 0.71 4.05
Secondary 39(29.8) 14(28) 1.24 0.48 3.24
Higher level 6(4.6) 0(0) 0.00 0.000
Knowledge about leishmaniasis Low 81(62.30) 42(76.36) Ref Ref Ref 0.129
Medium 46(35.38) 13(23.64) 0.545 0.265 1.119
High 3(2.32%) 0(0) 0.000 0.000

N: number, OR: Odd Ratio, CI: Confidence Interval, Ref: reference category.

Regarding population knowledge, the majority of cases and controls had low knowledge about the disease, while exclusively 2.32% had high knowledge about leishmaniasis. No significant correlation was detected between the knowledge variable and ACL, however, a negative correlation was noted between ACL and the level of study (Table 1, S1 Data).

2. Social and economic factors

Concerning the socio-economic characteristics (Table 2, S1 Data), most participants in the study are people living in a household of more than three people, but no significant association between household size and ACL disease was found (p = 0.460), unlike the number of children per household. In fact, 77.78% of the cases and 54.55% of the controls have more than two children, while 45.45% of the controls and only 22.22% of the cases have a number of children between 0 and 2. The risk of developing the ACL is higher in families with more than five children (OR = 1.61 95% CI: 0.12–21.39). On the one hand, the association between occupation and ACL is significant statistically (p = 0.056), as almost half of the cases and controls are unemployed, and 34% of the cases and 42.2% of the controls are artisans, farmers, workers or employees. The OR of ACL is the lowest (OR = 0.09) in Civil servants (95% CI: 0.01–0.72). A monthly salary of more than 5,000 Dirham can be a protective factor for ACL (OR = 0.06. 95% CI: 0.03–0.14).

Table 2. Socio-economic determinants associated with ACL, in the Marrakech-Safi region, Morocco between 2018 and 2020.

Variables Modalities Case Control OR CI for Exp(B) 95% P-value
N (%) N (%) Lower Upper
Number of children per family < 2 12(22.22) 10(45.45) Ref Ref Ref
2 to 5 29(53.70) 5(22.73) 1.33 0.12 13.65 0.130
> 5 13(24.08) 7(31.82) 1.61 0.12 21.39
Person per household < 2 7(5.56) 0(0) Ref Ref Ref 0.460
2 to 5 63(50) 7(50) 0.00 0.00 0.00
> 5 56(44.45) 7(50) 0.89 0.30 2.70
Province Al Haouz 52(20.16) 110(27.85) Ref Ref Ref 0.000
Chichaoua 82(31.78) 26(6.58) 1.28 0.29 5.62
Essaouira 21(8.14) 19(4.81) 5.34 1.19 24.03
Marrakech 90(34.88) 212(53.67) 1.91 0.94 9.15
Rhamna 10(3.88) 23(5.82) 0.69 0.16 2.97
Youssoufia 3(1.16) 5(1.27) 0.74 0.15 3.70
Monthly income (dhs) < 2000 57(50.4) 0(0) Ref Ref Ref 0.000
2000–5000 44(38.9) 11(17.2) 0.00 0.00 0.00
> 5000 12(10.6) 53(82.8) 0.06 0.03 0.14
Zone Urbain 73(28.40) 185(62.29) Ref Ref Ref 0.000
Rural 184(71.60) 112(37.71) 4.17 2.91 6.00
Travel to endemic area No 75(42.61) 232(77.08) Ref Ref Ref 0.000
Yes 101(57.39) 69(22.92) 4.53 3.03 6.77
Profession C1  22(44) 26(57.8) Ref Ref Ref 0.019
C2  17(34) 19(42.2) 0.68 0.03 1.57
C3  7(14) 0(0) 0.09 0.01 0.72
C4  4(8) 0(0) 0.15 0.02 1.38

C1: No profession, C2: Craftsmen, farmers, workers, employees…, C3: Civil servants, C4: Liberal professions, large traders, N: number, OR: Odd ratio, CI: confidence interval, Ref: reference category, dhs: Dirham.

The presence of the disease was strongly associated with origin (p≤0.001). Our results confirm that the risk of ACL in Essaouira is 5.34 times higher (95% CI: 1.19–24.03), followed by Marrakech (OR = 1.91) and Chichaoua (OR = 1.28). Among the ACL cases, 57.39% were moved to an endemic area. The majority of controls (77.08%) have no notion of recent travel to endemic area. This showed a strong association between the disease and population displacement (p≤0.001). The chance of acquiring ACL is 4.53 times higher for displaced people (95% CI: 3.03–6.77). Regarding the living environment, 71.60% of ACL cases against only 37.71% of controls were from rural area. A strong association was explored between the residence area and the disease (p≤0.001). The risk of ACL is 4.17 times higher (CI 95%: 2.91–5.96) in rural area compared to the urban setting.

3. Environmental factors

Two-thirds (65.39%) of the cases did not have a sanitation and waste management system (Table 3, S1 Data), there is a strong association between sanitation/ waste management system and the ACL disease (p≤0.001). The absence of a sanitation and waste management system tended to increase the risk of ACL 1.63 times (95% CI: 1.35–1.96). However, in this study, there was no significant association between the disease and the provision of toilets and wastewater management.

Table 3. Environmental determinants of ACL in Marrakech-Safi region, Morocco, between 2018 and 2020.

Variables Madalities Case Control OR CI for Exp (B) 95% P-value
N % N % Lower Upper
Sewage system/waste management Yes 45 34.61 187 59.74 0.58 0.45 0.75 0.000
No 85 65.39 126 40.26 1.63 1.35 1.96
Toilet/ Waste water management Yes 51 46.36 185 59.10 0.93 0.77 1.11 0.222
No 59 53.64 128 40.90 1.11 0.88 1.40
Mosquito nets Presence 35 27.13 2 12.50 2.17 0.58 8.18 0.169
Absence 94 72.87 14 83.50 0.84 0.68 1.03
Vegetation Presence 95 74.80 61 89.70 0.84 0.84 0.95 0.009
Absence 32 25.20 7 10.30 2.45 2.45 5.25
Farm animals Presence 70 55.12 6 37.50 1.47 1.47 2.82 0.143
Absence 57 44.88 10 62.50 0.72 0.72 1.10
Companion animals Presence 70 66.67 5 25.00 2.67 2.67 5.77 0.001
Absence 35 33.33 15 75.00 0.45 0.45 0.65

N: number, OR: Odd ratio, CI: confidence interval

Inside housing, the majority of cases (72.87%) and majority of controls (83.50%) do not use mosquito nets to protect themselves from sand flies and other insects. In contrast, the use of mosquito nets was considered a risk factor (OR = 2.17; 95% CI 0.58–8.18) in the present study.

Presence of vegetation was also associated with ACL (p = 0.009), most cases (74.80%) and controls (89.70%) had vegetation around their housing. Its absence seemed to increase the risk of ACL 2.45 times (95% CI 1.14–5.25). Finally, presence of companion animals in close proximity to habitants increase the risk of ACL (OR = 2.67 CI 95%1.14–5.25) (Table 3).

Discussion

With the aim to detect the main risk factors of ACL in Morocco, many variables were analyzed in the present study. In our results, socioeconomic factors are most significant variables, corroborating with the results of other study that confirm the association of socioeconomic factors with the disease incidence in vulnerable human populations of arid and tropical developing regions [29]. Overcrowded housing attracts sand flies because it is a good source of blood meals [30]. In addition, there is a strong association between the disease and travel to endemic area, which is consistent with other studies showing that the number of cases is increasing according to the increasing number of travelers returning from endemic countries [31]. Regarding occupation, the association with ACL was negatively significant, and the category of civil servants people can be a protective factor for ACL. Generally, outdoor occupations increase the risk of leishmaniasis incidence due to a greater risk of contact with the sand fly vectors [32]. In the other hand, a salary above 5,000 Dirham is a protective factor for ACL, this result is in agreement with a study in Brazil that confirms that the presence of cutaneous leishmaniasis is more important in economically active adults, whose monthly income does not exceed 5,000$ [33]. In the same sense, according to several authors, poverty could be the main determinant of the transmission of leishmaniasis, especially its visceral form [30, 31], as well as the cutaneous form [34]. Conversely, authors in Morocco did not associate the poverty rate with the distribution of cutaneous leishmaniasis [21, 35]. That can be explained by the economic homogeneity of their study population.

The rural environment is associated with a risk of ACL compared to the urban environment. This result is similar to most of the studies conducted in Morocco and elsewhere, on visceral [20], as well as for cutaneous leishmaniasis [34, 36, 37]. The present study shows also that the presence of ACL disease is strongly associated with provenance. The risk comes mainly from Chichaoua and Essaouira, as these Provinces are active foci of cutaneous leishmaniasis [13]. Indeed, the proximity to cases within 50 meters is a risk factor for visceral leishmaniasis [30]. The city of Marrakech may also be at risk of ACL, this result can be explained by urbanization which has a significant effect on the distribution of sand flies the vector and consequently the disease [21, 38]. Certainly, the movement of people from rural to urban area, where housing conditions are unfavorable, contributes to the emergence of the disease [39].

Regarding the environmental factors, our findings show the presence of livestock and the placement of companion animals in close proximity to habitants increase the risk of ACL. This is consistent with previous investigation that confirms an association between cutaneous leishmaniasis and keeping animals at home and in peri-domestic area [33]. The presence of toilets, water pipes and, consequently, a sewage disposal system reduces the incidence of leishmaniasis [33]. Indeed, housing conditions and domestic hygiene are major determinants in the spread of visceral [31] and cutaneous leishmaniasis [40], as they may increase the breeding and rest biotopes of sand flies, as well as their access to humans. Improved housing conditions and personal protection efforts by the poor have the potential to reduce the incidence of visceral leishmaniasis [30]. Inside the home, the majority of local population did not use mosquito nets to be protected from sand flies; this variable was oddly considered as a risk factor. In a study in Pakistan, 63% of infected people with cutaneous leishmaniasis had used mosquito nets [41]. Whereas mosquito nets are a primary form of vector control, especially those impregnated with insecticides [42, 43]. In Iran, several studies confirmed the effect of these strategies for controlling of zoonotic cutaneous leishmaniasis [44] and ACL [45]. Our result can be explained by adoption of these preventive measures exclusively in the active foci of leishmaniasis, where control program is solicited and implemented by the local Health System [46]. Based on significant association between vegetation and ACL disease, vegetation is considered in our study as a protective factor. Conversely, several studies confirm its positive association with the distribution of cutaneous leishmaniasis [47], mainly natural vegetation [29, 48, 49]. Sand flies are more abundant where vegetation cover and density were greater [50]. The incidence of the disease is associated with a normalized difference in vegetation index (NDVI) [18, 51] and in some cases, deforestation rather reduces human infection [27]. Similarly in Morocco, NDVI showed positive correlation with density of Phlebotomus sergenti, the proven vector of ACL [8]. However, others results showed different patterns and magnitudes of the lagged relationship between the vegetation index and cutaneous leishmaniasis incidence [51]. Our results can be explained in one hand by sand fly dispersal, oviposition and feeding behavior. In fact, the results in India showed the mean number of sand flies were significantly higher in banana trees than in other vegetation and in female palmyra palm trees [52]. In other hand, vegetation is not the only factor that influences the incidence of cutaneous leishmaniasis. Other factors, such as temperature, rainfall, and floating population, may also affect the prevalence of the disease [45].

Among the socio-demographic factors only marital status is related to ACL. The risk of developing ACL is four times higher in married than single people in the study area. Although marital status showed significant association with the disease (married people are protected to be affected) in Sri Lanka, it cannot significantly predict the disease incidence [53]. These significant statistic relationships in the univariate analysis are likely to be a result of confounding effects [54], which is not the case of the present study because of the use of regression models [54].

Our results show a predominance of the age category 19–40 years in cases, contrary to other studies that have found the incidence of ACL higher in children [37] between 5 and 14 years [55], and at young age 0–9 years [17, 39]. Generally, the highest prevalence of visceral leishmaniasis is found in children [20, 33, 56], whereas cutaneous leishmaniasis occurs mainly in adult [14, 36, 56]. No association was determined between gender and the disease, corroborating with results of many authors [57, 58]. The preponderance of ACL in females was highlighted [39, 55], however, others confirm a positive association with males in cutaneous cases [14, 33, 36, 37], especially ACL form [33, 37]. Similarly, our study shows no significant association between education level and ACL, while a low level of education is associated with the presence of ACL in other studies [37]. In the same way, we noted no significant association between ACL and the knowledge about the disease, as found by Alhrazi et al, [59]. This result may be attributed to the general lack of awareness and education about ACL disease in the local context. In India, the lack knowledge regarding visceral leishmaniasis was correlated to a low level of education and a low socio-economic status [60].

In sum, sex, education, gender, knowledge, number of children per family, person per family, Toilet/Waste water management, mosquito nets and farm animals were not significantly associated with the incidence of leishmaniasis. However, monthly income, residence zone, travel to endemic area, companion animals, sewage system/waste management and vegetation are potentially linked to ACL. The results suggest that it may be possible to modify a portion of the risk of ACL by making changes in the housing environment which may help to reduce the human–vector contact. Our finding suggests also improving the awareness of the population in endemic and non-endemic areas about the prevention measures, to gain their participation in the fight against the disease through education of local human population.

Conclusion

This study emphasizes the role of socio-economic and environmental components as the main determinants of ACL incidence in Morocco. Control efforts must be focused on more effective preventive measures that combine the efforts of various sectors. Education, through community participation, thus encourages the population to improve their own hygiene and environmental conditions.

Supporting information

S1 Data. Data analysis results.

(SAV)

Acknowledgments

Authors thank warmly Jenna Lacey for English revision.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Kahime K, Boussaa S, Bounoua L, Fouad O, Messouli M, Boumezzough A. Leishmaniasis in Morocco: diseases and vectors. Asian Pac J Trop Dis. 1 sept 2014;4:S530‑4. [Google Scholar]
  • 2.Rhajaoui M. Human leishmaniases in Morocco: A nosogeographical diversity. Pathol Biol. 1 aug. Pathol Biol. 1 août 2011;59(4):226‑9. [DOI] [PubMed] [Google Scholar]
  • 3.Boussaa S, Pesson B, Boumezzough A. Faunistic study of the sandflies (Diptera: Psychodidae) in an emerging focus of cutaneous leishmaniasis in Al Haouz province, Morocco. Ann Trop Med Parasitol. jan 2009;103(1):73‑83. doi: 10.1179/136485909X384910 [DOI] [PubMed] [Google Scholar]
  • 4.Ramaoui K, Guernaoui S, Boumezzough A. Entomological and epidemiological study of a new focus of cutaneous leishmaniasis in Morocco. Parasitol Res. sept 2008;103(4):859‑63. [DOI] [PubMed] [Google Scholar]
  • 5.Rhajaoui M, Fellah H, Pratlong F, Dedet JP, Lyagoubi M. Leishmaniasis due to Leishmania tropica MON-102 in a new Moroccan focus. Trans R Soc Trop Med Hyg. mai 2004;98(5):299‑301. [DOI] [PubMed] [Google Scholar]
  • 6.Ajaoud M, Es-sette N, Hamdi S, El-Idrissi AL, Riyad M, Lemrani M. Detection and molecular typing of Leishmania tropica from Phlebotomus sergenti and lesions of cutaneous leishmaniasis in an emerging focus of Morocco. Parasit Vectors. 26 jul 2013;6:217. doi: 10.1186/1756-3305-6-217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Pratlong F, Rioux JA, Dereure J, Mahjour J, Gallego M, Guilvard E, et al. [Leishmania tropica in Morocco. IV—Intrafocal enzyme diversity]. Ann Parasitol Hum Comp. 1991;66(3):100‑4. [DOI] [PubMed] [Google Scholar]
  • 8.Boussaa S, Kahime K, Samy AM, Salem AB, Boumezzough A. Species composition of sand flies and bionomics of Phlebotomus papatasi and P. sergenti (Diptera: Psychodidae) in cutaneous leishmaniasis endemic foci, Morocco. Parasit Vectors [Internet]. 2 feb 2016;9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736259/ [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Dereure J, Rioux JA, Gallego M, Perières J, Pratlong F, Mahjour J, et al. Leishmania tropica in Morocco: infection in dogs. Trans R Soc Trop Med Hyg. oct 1991;85(5):595. [DOI] [PubMed] [Google Scholar]
  • 10.Guessous-Idrissi N, Chiheb S, Hamdani A, Riyad M, Bichichi M, Hamdani S, et al. Cutaneous leishmaniasis: an emerging epidemic focus of Leishmania tropica in north Morocco. Trans R Soc Trop Med Hyg. 1 nov 1997;91(6):660‑3. [DOI] [PubMed] [Google Scholar]
  • 11.Lemrani M, Nejjar R, Pratlong F. A new Leishmania tropica zymodeme—causative agent of canine visceral leishmaniasis in northern Morocco. Ann Trop Med Parasitol. sept 2002;96(6):637‑8. [DOI] [PubMed] [Google Scholar]
  • 12.Echchakery M, Chicharro C, Boussaa S, Nieto J, Carrillo E, Sheila O, et al. Molecular detection of Leishmania infantum and Leishmania tropica in rodent species from endemic cutaneous leishmaniasis areas in Morocco. Parasit Vectors. 2 oct 2017;10(1):454. doi: 10.1186/s13071-017-2398-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Bulletin D’épidémiologie Et de Santé Publique (JuLY 2018) N° 76 | PDF | Organisation mondiale de la santé | Risque [Internet]. Scribd. https://fr.scribd.com/document/495509588/Bulletin-d-epidemiologie-et-de-sante-publique-Juillet-2018-N-76-1.
  • 14.Oliveira RS, Pimentel KBA, Moura ML, Aragão CF, Guimarães-e-Silva AS, Bezerra JMT, et al. Clinical, epidemiological and climatic factors related to the occurrence of cutaneous leishmaniasis in an endemic area in northeastern Brazil. Braz J Biol. sept 2021;81(3):557‑65. doi: 10.1590/1519-6984.224937 [DOI] [PubMed] [Google Scholar]
  • 15.Samuel Singh N. A Review on Major Risk Factors and Current Status of Visceral Leishmaniasis in North India. Am J Entomol. 2019;3(1):6. [Google Scholar]
  • 16.Boussaa S, Guernaoui S, Pesson B, Boumezzough A. Seasonal fluctuations of phlebotomine sand fly populations (Diptera: Psychodidae) in the urban area of Marrakech, Morocco. Acta Trop. aug 2005;95(2):86‑91. doi: 10.1016/j.actatropica.2005.05.002 [DOI] [PubMed] [Google Scholar]
  • 17.Baghad B, Razanapinaritra R, Maksouri H, El Bouri H, Outlioua A, Fellah H, et al. Possible introduction of Leishmania tropica to urban areas determined by epidemiological and clinical profiles of patients with cutaneous leishmaniasis in Casablanca (Morocco). Parasite Epidemiol Control. 1 mai 2020;9:e00129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Shirzadi MR, Javanbakht M, Vatandoost H, Jesri N, Saghafipour A, Fouladi-Fard R, et al. Impact of Environmental and Climate Factors on Spatial Distribution of Cutaneous Leishmaniasis in Northeastern Iran: Utilizing Remote Sensing. J Arthropod-Borne Dis. mar 2020;14(1):56‑67. doi: 10.18502/jad.v14i1.2704 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Boussaa S. Épidémiologie des leishmanioses dans la région de Marrakech, Maroc: Effet de l’urbanisation sur la répartition spatio-temporelle des phlébotomes et caractérisation moléculaire de leurs populations [Internet] [thesis]. Strasbourg 1; 2008. http://www.theses.fr/2008STR13037 [Google Scholar]
  • 20.Kahime K, Boussaa S, Nhammi H, Boumezzough A. Urbanization of human visceral leishmaniasis in Morocco. Parasite Epidemiol Control. nov 2017;2(4):1‑6. doi: 10.1016/j.parepi.2017.07.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.El Omari H, Chahlaoui A, Talbi F, Ouarrak K, El Ouali Lalami A. Impact of Urbanization and Socioeconomic Factors on the Distribution of Cutaneous Leishmaniasis in the Center of Morocco. Interdiscip Perspect Infect Dis. 3 jan 2020;2020:e2196418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.High Planning Commission. General Census of Population and Housing 2014 [Internet]. 2014. https://www.hcp.ma/downloads/RGPH-2014_t17441.html [Google Scholar]
  • 23.High Planning Commission. REGIONAL MONOGRAPH REGION OF MARRAKECH–SAFI 2018. [Internet]. https://www.hcp.ma/region-marrakech/PRESENTATION-DE-LA-REGION-DE-MARRAKECH-SAFI_a248.html [Google Scholar]
  • 24.Farah A, Algouti A, Algouti A, Adaze E, Ifkirne M. Remote Sensing for Land Use Mapping, Case of The Study Area: Urban Commune of Saada, Morocco. J Environ Agric Stud. 20 févr 2021;2(1):36‑43. [Google Scholar]
  • 25.OpenEpi Menu [Internet]. [cité 4 mars 2022]. https://www.openepi.com/Menu/OE_Menu.htm
  • 26.Ury HK. Continuity-Corrected Approximations to Sample Size or Power When Comparing Two Proportions: Chi-Squared or Arc Sine? J R Stat Soc Ser Stat. 1981;30(3):199‑203. [Google Scholar]
  • 27.World Health Organization. Regional Office for the Eastern Mediterranean. (‎2014)‎. Manual for case management of cutaneous leishmaniasis in the WHO Eastern Mediterranean Region. https://apps.who.int/iris/handle/10665/120002
  • 28.Nackers F, Mueller YK, Salih N, Elhag MS, Elbadawi ME, Hammam O, et al. Determinants of Visceral Leishmaniasis: A Case-Control Study in Gedaref State, Sudan. PLoS Negl Trop Dis. 6 nov 2015;9(11):e0004187. doi: 10.1371/journal.pntd.0004187 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Valero NNH, Uriarte M. Environmental and socioeconomic risk factors associated with visceral and cutaneous leishmaniasis: a systematic review. Parasitol Res. 1 feb 2020;119(2):365‑84. doi: 10.1007/s00436-019-06575-5 [DOI] [PubMed] [Google Scholar]
  • 30.Mandal PK, Wagle RR, Thakur AK, Uranw S. “Risk Factors for Visceral Leishmaniasis in Selected High Endemic Areas of Morang District, Nepal”: A case control study. bioRxiv. 25 jan 2019;530741. [Google Scholar]
  • 31.Oryan A, Akbari M. Worldwide risk factors in leishmaniasis. Asian Pac J Trop Med. 1 oct 2016;9(10):925‑32. doi: 10.1016/j.apjtm.2016.06.021 [DOI] [PubMed] [Google Scholar]
  • 32.Eid D, Guzman-Rivero M, Rojas E, Goicolea I, Hurtig AK, Illanes D, et al. Risk factors for cutaneous leishmaniasis in the rainforest of Bolivia: a cross-sectional study. Trop Med Health. 2018;46:9. doi: 10.1186/s41182-018-0089-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Araujo AR, Portela NC, Sampaio Feitosa AP, da Silva OA, Arraes Ximenes RA, Alves LC, et al. Risk Factors Associated with American Cutaneous Leishmaniasis in an Endemic Area of Brazil. Rev Inst Med Trop Sao Paulo. 2016;58:86. doi: 10.1590/S1678-9946201658086 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.El Alem MMM, Hakkour M, Hmamouch A, Halhali M, Delouane B, Habbari K, et al. Risk factors and prediction analysis of cutaneous leishmaniasis due to Leishmania tropica in Southwestern Morocco. Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis. 2018;61:84‑91. doi: 10.1016/j.meegid.2018.03.017 [DOI] [PubMed] [Google Scholar]
  • 35.Talbi FZ, Najy M, Nouayti N, En-nkhili H, El Ouali Lalami A. Cutaneous Leishmaniasis cases and risk factors in north central of Morocco, Sefrou province: An impact study. Abouchabaka J, Bourekkadi S, Omari O, Slimani K, éditeurs. E3S Web Conf. 2021;234:00027. [Google Scholar]
  • 36.Almeida JV, de Souza CF, Fuzari AA, Joya CA, Valdivia HO, Bartholomeu DC, et al. Diagnosis and identification of Leishmania species in patients with cutaneous leishmaniasis in the state of Roraima, Brazil’s Amazon Region. Parasit Vectors. 7 janv 2021;14(1):32. doi: 10.1186/s13071-020-04539-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Luckwu de Santana Goncalves AF, de Lima SS, de Santana Cabral Silva AP, Barbosa CC. Spatial dynamics and socioeconomic factors correlated with American cutaneous leishmaniasis in Pernambuco, Brazil from 2008 to 2017. Rev Soc Bras Med Trop. 2020;53:e20190373. doi: 10.1590/0037-8682-0373-2019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Boussaa S, Pesson B, Boumezzough A. Phlebotomine sandflies (Diptera: Psychodidae) of Marrakech city, Morocco. Ann Trop Med Parasitol. dec 2007;101(8):715‑24. doi: 10.1179/136485907X241398 [DOI] [PubMed] [Google Scholar]
  • 39.El Miri H, Faraj C, Himmi O, Hmamouch A, Maniar S, Laaroussi T, et al. Cutaneous leishmaniasis in Ouazzane and Sidi Kacem provinces, Morocco (1997–2012). Bull Société Pathol Exot. 1 dec 2016;109(5):376‑80. [DOI] [PubMed] [Google Scholar]
  • 40.Bamorovat M, Sharifi I, Aflatoonian MR, Sharifi H, Karamoozian A, Sharifi F, et al. Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran. PLOS ONE. 7 feb 2018;13(2):e0192236. doi: 10.1371/journal.pone.0192236 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Mashhood AA, Malik SS, Haq MMU, Khan QU. Awareness and practice of preventive strategies in patients of cutaneous leishmaniasis. PAFMJ. 31 dec 2018;68(6):1683‑5. [Google Scholar]
  • 42.Bardin M, Aletti M, Cournac JM, Doutrelon C, Jacquier C, Zinc E, et al. L’amphotéricine B liposomale: une alternative thérapeutique intéressante dans le traitement de la leishmaniose cutanée à Leishmania tropica. Rev Médecine Interne. 1 jun 2016;37:A190. [Google Scholar]
  • 43.Emami M.M., Yazdi M. & Guillet P. (‎2009)‎. Efficacy of Olyset long-lasting bednets to control transmission of cutaneous leishmaniasis in Iran. EMHJ—Eastern Mediterranean Health Journal, 15 (‎5)‎, 1075–1083, 2009. https://apps.who.int/iris/handle/10665/117735 [PubMed] [Google Scholar]
  • 44.Yaghoobi-Ershadi MR, Moosa-Kazemi SH, Zahraei-Ramazani AR, Jalai-Zand AR, Akhavan AA, Arandain MH, et al. Evaluation of deltamethrin-impregnated bed nets and curtains for control of zoonotic cutaneous leishmaniasis in a hyperendemic area of Iran. Bull Soc Pathol Exot 1990. mar 2006;99(1):43‑8. [DOI] [PubMed] [Google Scholar]
  • 45.Moosa-Kazemi SH, Yaghoobi-Ershadir MR, Akhavan AA, Abdoli H, Zahraei-Ramazani AR, Jafari R, et al. Deltamethrin-impregnated bed nets and curtains in an anthroponotic cutaneous leishmaniasis control program in northeastern Iran. Ann Saudi Med.feb 2007;27(1):6‑12. doi: 10.5144/0256-4947.2007.6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Boussaa S, Daoudi M, Ouzennou N. Assessment of the implementation of action plan against cutaneous leishmaniasis in Morocco: case of Essaouira focus. J Biomed Res Health Econ. 2020;1(3):4‑8. [Google Scholar]
  • 47.Ngere I, Boru WG, Isack A, Muiruri J, Obonyo M, Matendechero S, et al. Burden and risk factors of cutaneous leishmaniasis in a peri-urban settlement in Kenya, 2016. PLOS ONE. 23 jan 2020;15(1):e0227697. doi: 10.1371/journal.pone.0227697 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Melo HA, Rossoni DF, Teodoro U. Effect of vegetation on cutaneous leishmaniasis in Parana, Brazil. Mem Inst Oswaldo Cruz. 2018;113(6):e170505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Rodrigues MG de A, Sousa JD de B, Dias ÁLB, Monteiro WM, Sampaio V de S. The role of deforestation on American cutaneous leishmaniasis incidence: spatial-temporal distribution, environmental and socioeconomic factors associated in the Brazilian Amazon. Trop Med Int Health. 2019;24(3):348‑55. doi: 10.1111/tmi.13196 [DOI] [PubMed] [Google Scholar]
  • 50.Chanampa MDM, Gleiser RM, Hoyos CL, Copa GN, Mangudo C, Nasser JR, et al. Vegetation Cover and Microspatial Distribution of Sand Flies (Diptera: Psychodidae) in an Endemic Locality for Cutaneous Leishmaniasis in Northern Argentina. J Med Entomol. 25 oct 2018;55(6):1431‑9. doi: 10.1093/jme/tjy129 [DOI] [PubMed] [Google Scholar]
  • 51.Gutiérrez-Torres JD. Temporal lagged relationship between a vegetation index and cutaneous leishmaniasis cases in Colombia: an analysis implementing a distributed lag nonlinear model. Parasitol Res. mar 2020;119(3):1075‑82. doi: 10.1007/s00436-019-06592-4 [DOI] [PubMed] [Google Scholar]
  • 52.Poché DM, Poché RM, Mukherjee S, Franckowiak GA, Briley LN, Somers DJ, et al. Phlebotomine sandfly ecology on the Indian subcontinent: does village vegetation play a role in sandfly distribution in Bihar, India? Med Vet Entomol. jun 2017;31(2):207‑13. doi: 10.1111/mve.12224 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Wijerathna T, Gunathilaka N, Gunawardena K, Rodrigo W. Socioeconomic, demographic and landscape factors associated with cutaneous leishmaniasis in Kurunegala District, Sri Lanka. Parasit Vectors. dec 2020;13(1):244. doi: 10.1186/s13071-020-04122-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Pourhoseingholi MA, Baghestani AR, Vahedi M. How to control confounding effects by statistical analysis. Gastroenterol Hepatol Bed Bench. 2012;5(2):79‑83. [PMC free article] [PubMed] [Google Scholar]
  • 55.Laboudi M. Epidemiological profile of cutaneous leishmaniasis in Morocco, 2004–2013. Médecine Santé Trop. 1 jan 2017;27(1):44‑51. [DOI] [PubMed] [Google Scholar]
  • 56.Lacerda AFA, Oliveria DS, Salomão JVF, Oliveira LGR, Monte-Alegre A, Santos JYG dos, et al. Clinical, epidemiological and transmission cycle aspects of leishmaniasis urbanization in Barreiras, Bahia, Brazil. Spat Spatio-Temporal Epidemiol. 1 feb 2021;36:100395. doi: 10.1016/j.sste.2020.100395 [DOI] [PubMed] [Google Scholar]
  • 57.Ait Kbaich M, Mhaidi I, Ezzahidi A, Dersi N, El Hamouchi A, Riyad M, et al. New epidemiological pattern of cutaneous leishmaniasis in two pre-Saharan arid provinces, southern Morocco. Acta Trop. 1 sept 2017;173:11‑6. doi: 10.1016/j.actatropica.2017.05.016 [DOI] [PubMed] [Google Scholar]
  • 58.Hakkour M, El Alem MM, Hmamouch A, Rhalem A, Delouane B, Habbari K, et al. Leishmaniasis in Northern Morocco: Predominance of Leishmania infantum Compared to Leishmania tropica. Biomed Res Int. 2019. Aug 8;2019:5327287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Alharazi TH, Haouas N, Al-Mekhlafi HM. Knowledge and attitude towards cutaneous leishmaniasis among rural endemic communities in Shara’b district, Taiz, southwestern Yemen. BMC Infect Dis. 17 mar 2021;21(1):269. doi: 10.1186/s12879-021-05965-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Guha U, Chatterjee M, Sardar AA, Jana K, Saha P, Maji AK, et al. Assessment of Knowledge, Attitudes, and Practices about Visceral Leishmaniasis in Endemic Areas of Malda District, West Bengal, India. Am J Trop Med Hyg. 3 feb 2021;104(2):646‑52. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Albert Schriefer

4 May 2022

PONE-D-22-07886Determinants of Anthroponotic Cutaneous Leishmaniasis by Case-Control Study in MoroccoPLOS ONE

Dear Dr. Boussa,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Both reviewers acknowledged the relevance of the study in updating aspects of the current knowledge of cutaneous leishmaniasis endemics in Morocco. They also made valuable comments that would help to improve language, distribution of information, and description of the study, as well as to clarify some points in the report. Please, make sure you thoroughly address all issues raised by both reviewers, and attempt to incorporate a substantial proportion of the suggestions in a revised version of the manuscript.

Please submit your revised manuscript by Jun 18 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Albert Schriefer, M.D., Ph.D.

Section Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

3. Please amend either the abstract on the online submission form (via Edit Submission) or the abstract in the manuscript so that they are identical.

4. We note that Figure 1 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a)  You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license.  

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b) If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In the current study, some important determinants of local anthroponotic cutaneous leishmaniasis are investigated in Morocco.

Introduction:

Line 47: At the beginning of each sentence the scientific names must be in complete form (L. tropica must be changed to Leishmania tropica).

Results:

There are some errors in table 2 which must be corrected (in Gender line after parenthesis if cases”1” must be deleted. In the line of level of study, “Literary” is misspelled).

Sandfly/sandflies should be written separately (sand fly/ sand flies) in the manuscript.

Line 272: Scientific names must be written in italic form (P. sergenti must be in italic).

Discussion:

Lines 212-223 are not related to the discussion. These sentences can be included in the introduction.

The results should not be repeated in discussion. All p values in the discussion should be omitted. In discussion, the results should be compared with the results of other studies and described.

In the last paragraph of the discussion (lines: 293-301) all factors should be included. Using mosquito nets is missed.

There are many valuable published articles by Iranian scientists. It is recommended that the authors of the current manuscript use them for the introduction and results. For example for the effect of mosquito nets on cutaneous leishmaniasis the following references can be used:

-Moosa-Kazemi SH, Yaghoobi-Ershadi MR, Akhavan AA, Abdoli H, Zahraei-Ramazani AR, Jafari R, Houshmand B, Nadim A, Hosseini M. (2007) Deltamethrin-impregnated bed nets and curtains in an anthroponotic cutaneous leishmaniasis control program in northeastern Iran. Ann Saudi Med. 27(1): 6–12.

- Yaghoobi-Ershadi MR, Moosa-Kazemi SH, Zahraei-Ramazani AR, Jalali-Zand AR, Akhavan AA, Arandian MH, Abdoli H, Houshmand B, Nadim A, Hosseini M. (2006) Evaluation of deltamethrin-impregnated bed nets and curtains for control of zoonotic cutaneous leishmaniasis in a hyperendemic area of Iran. Bull Soc Pathol Exot. 99(1): 43–48.

Reviewer #2: Line 15: "Are" should be replaced with "is".

Line 28: Whether absent of sewage system is beneficial or its presence? its unclear. Please rephrase the sentence.

Line 38: "Are" should be replaced with "is".

Line 54: Here the reference, Boussaa et al is not cited properly, i.e. by numbering. Please do the needful.

Line 99-103: Please explain more about sample size calculation. It is not well explained at all.

Line 119-122: How the data was tabulated and how categorization was done? This part can be more explained for better understanding, like what is the process of categorization etc.

Line 136: Please mention whether the consent taken is written or verbal.

Line 147: Change the phrase as : "females are more affected".

Line 193-195: Sentence is not properly understood. Please re-phrase the sentence.

Line 202: Rephrase the sentence as : presence of vegetation.

Line 224: Use of reference 27 is not understood. You have sated about your study findings here, so how reference 27 is appropriate here?

Line 230: How is this associated? Negatively or positively?

Line 267-275: This part could be better explained, why there is such finding, whats the reason behind it.

Line 278-279: Please explain.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Amir Ahmad Akhavan

Reviewer #2: Yes: Dr. Moytrey Chatterjee

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Oct 14;17(10):e0266291. doi: 10.1371/journal.pone.0266291.r002

Author response to Decision Letter 0


21 Jun 2022

RESPONSE LETTER

PONE-D-22-07886

Determinants of Anthroponotic Cutaneous Leishmaniasis by Case-Control Study in Morocco

PLOS ONE

Dear Editor,

Thank you for the opportunity to submit a revised version of our manuscript entitled “Determinants of Anthroponotic Cutaneous Leishmaniasis by Case-Control Study in Morocco”. We appreciate the time and efforts you and the reviewers have put into providing your valuable comments on our manuscript. We are grateful for your insightful comments on our paper. We were able to incorporate changes to reflect all the suggestions provided.

We have highlighted the changes in the manuscript.

Sincerely,

Pr S. BOUSSAA

Corresponding author

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Authors: The revised manuscript was formatted according to PLOS ONE's style

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

Authors: The ethics statement section has been rewritten, based on comments from the editor and reviewer, to be more informative.

3. Please amend either the abstract on the online submission form (via Edit Submission) or the abstract in the manuscript so that they are identical.

Authors: The abstract on the online submission was updated.

4. We note that Figure 1 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a) You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b) If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

Authors: Figures 1 and 2 were performed by authors; consequently we can publish it on open access form under CC BY 4.0. We used free sheapfile from https://mapcruzin.com/free-morocco-arcgis-maps-shapefiles.htm, for map creation (Fig. 1).

Figures were presented under TIF format and titles were modified according to the journal recommendations’

Reviewer #1:

In the current study, some important determinants of local anthroponotic cutaneous leishmaniasis are investigated in Morocco.

Introduction:

Line 47: At the beginning of each sentence the scientific names must be in complete form (L. tropica must be changed to Leishmania tropica).

Authors:

Thank you to the Reviewer for the positive feedback and useful comments. This remark has been corrected throughout the manuscript.

Results:

There are some errors in table 2 which must be corrected (in Gender line after parenthesis if cases”1” must be deleted. In the line of level of study, “Literary” is misspelled).

Authors: Tables were modified according to Reviewer comments

Sandfly/sandflies should be written separately (sand fly/ sand flies) in the manuscript.

Line 272: Scientific names must be written in italic form (P. sergenti must be in italic).

Authors: These remarks have been corrected throughout the manuscript.

Discussion:

Lines 212-223 are not related to the discussion. These sentences can be included in the introduction.

The results should not be repeated in discussion. All p values in the discussion should be omitted. In discussion, the results should be compared with the results of other studies and described.

In the last paragraph of the discussion (lines: 293-301) all factors should be included. Using mosquito nets is missed.

There are many valuable published articles by Iranian scientists. It is recommended that the authors of the current manuscript use them for the introduction and results. For example for the effect of mosquito nets on cutaneous leishmaniasis the following references can be used:

-Moosa-Kazemi SH, Yaghoobi-Ershadi MR, Akhavan AA, Abdoli H, Zahraei-Ramazani AR, Jafari R, Houshmand B, Nadim A, Hosseini M. (2007) Deltamethrin-impregnated bed nets and curtains in an anthroponotic cutaneous leishmaniasis control program in northeastern Iran. Ann Saudi Med. 27(1): 6–12.

- Yaghoobi-Ershadi MR, Moosa-Kazemi SH, Zahraei-Ramazani AR, Jalali-Zand AR, Akhavan AA, Arandian MH, Abdoli H, Houshmand B, Nadim A, Hosseini M. (2006) Evaluation of deltamethrin-impregnated bed nets and curtains for control of zoonotic cutaneous leishmaniasis in a hyperendemic area of Iran. Bull Soc Pathol Exot. 99(1): 43–48.

Authors: Thank you for these valuable remark and resources. The Discussion section was reviewed according to the comments and all references were included. Please see the revised version of the manuscript

Reviewer #2:

Line 15: "Are" should be replaced with "is".

Line 38: "Are" should be replaced with "is".

Authors: Thank you to the Reviewer for the positive feedback and useful comments. These remarks were fixed

Line 28: Whether absent of sewage system is beneficial or its presence? its unclear. Please rephrase the sentence.

Authors: According to our results, the absent of sewage system/waste management increases the risk of ACL which means that its presence is beneficial (protective factor). This sentence was reviewed in the revised version of the manuscript.

Line 54: Here the reference, Boussaa et al is not cited properly, i.e. by numbering. Please do the needful.

Authors: Thank you for this comment. The manuscript was revised according to the journal style.

Line 99-103: Please explain more about sample size calculation. It is not well explained at all.

Authors: We added a paragraph in material and methods section about sample size calculation in this case- control study.

Line 119-122: How the data was tabulated and how categorization was done? This part can be more explained for better understanding, like what is the process of categorization etc.

Authors: We added a paragraph at our opining paragraph of the material and methods section to help the reader to undesrstand : “The questionnaire has three sections covering socio-demographic (Gendre, Age, Matrimonial status, Level of study, knowledge about leishmaniasis), socioeconomic (Number of children per family, Person per household, Provinces, Monthly income (dhs), Zone, Travel to endemic area, Profession) and environmental data (Sewage system/waste management, Toilet/ Waste water management, Mosquito nets, Vegetation, Farm animals, Companion animals). The categorisation was based on previous studies exploring the factors of leishmaniasis in all its forms (28) (29)”. Please see the revised version of the manuscript.

Line 136: Please mention whether the consent taken is written or verbal.

Authors: The ethics statement section has been rewritten, based on comments from the editor and reviewer, to be more informative.

Line 147: Change the phrase as : "females are more affected".

Line 202: Rephrase the sentence as : presence of vegetation.

Authors: Phrases were changed accordantly

Line 193-195: Sentence is not properly understood. Please re-phrase the sentence.

Authors: This section was modified according to the Reviewer comments. Please see the revised version of the manuscript.

Line 224: Use of reference 27 is not understood. You have sated about your study findings here, so how reference 27 is appropriate here?

Authors: This paragraph was rephrased to be clearer.

Line 230: How is this associated? Negatively or positively?

Authors: This is associated negatively, we rectified it in manuscript

Line 267-275: This part could be better explained, why there is such finding, whats the reason behind it.

Authors: This part was developed and more explained according to the reviewer comment.

Line 278-279: Please explain.

Authors: This paragraph was rephrased to be clearer. Please see the revised version of the manuscript.

Attachment

Submitted filename: Response Letter PLOS.docx

Decision Letter 1

Albert Schriefer

13 Jul 2022

PONE-D-22-07886R1Determinants of Anthroponotic Cutaneous Leishmaniasis by Case-Control Study in MoroccoPLOS ONE

Dear Dr. Boussa,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

More specifically, please, address the minor issue regarding the citations raised by reviewer one. Also, please, kindly carry out one last round of language editing (detailed in the 'Additional Editor Comments' section at the end of this letter) before we can proceed to full acceptance of your manuscript.

Please submit your revised manuscript by Aug 27 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Albert Schriefer, M.D., Ph.D.

Section Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments :

Before we can proceed to acceptance, I would like to ask the authors for a last round of English language correction. There are several capitalization and punctuation mistakes affecting mostly the new text inserted to conform with the reviewers suggestions and comments. However, some mistakes are still present in the original text. So, please, make the language review thorough and cautious. The only intent of this demand is to make your study as clear as possible to the general audience, potentially increasing its reach.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

********** 

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

********** 

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thanks for considering my comments BUT some references in the text are not matched with the number indicated in the References section such as the references 45-47. Please check all references throughout the manuscript and match them with the corresponding number in the References section.

Reviewer #2: (No Response)

********** 

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Amir Ahmad Akhavan, Professor of Medical Entomology and Vector Control, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Reviewer #2: Yes: Dr. Moytrey Chatterjee

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 2

Albert Schriefer

9 Sep 2022

PONE-D-22-07886R2Determinants of Anthroponotic Cutaneous Leishmaniasis by Case-Control Study in MoroccoPLOS ONE

Dear Dr. Boussa,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

More specifically, please, kindly make the very minor edits suggested in the 'Additional Editor Comments' section below before we move on to acceptance of the manuscript.

Please submit your revised manuscript by Oct 24 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Albert Schriefer, M.D., Ph.D.

Section Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

Line 130, Methods. Please adjust the sentence 'a confirmed case of ACL is a person presents clinical signs' to read 'a confirmed case of ACL is a person that presents clinical signs'.

Line 208, Results. Please adjust the sentence 'The chance of acquiring ACL is 4.53 times more increased for displaced people' to read 'The chance of acquiring ACL is 4.53 times higher for displaced people'.

Line 234, Results. Please check if the word 'habitants' would not be the correct one, instead of 'habitats' in this sentence.

Line 249, Discussion. Please, adjust the sentence 'that category of civil servants people can be a protective factor for ACL' to read 'and the category of civil servants people can be a protective factor for ACL'.

Line 271, Discussion. Please check if the word 'habitants' would not be the correct one, instead of 'habitats' in this sentence.

Line 283, Discussion. Please, adjust the sentence 'several studies confirmed the effect of this strategies for control of zoonotic cutaneous leishmaniasis' to read 'several studies confirmed the effect of these strategies for controling of zoonotic cutaneous leishmaniasis'.

Line 330, Discussion. Please, adjust the sentence 'Our finding suggests also improving the awareness of the population in endemic and non-endemic area' to read 'Our finding suggests also improving the awareness of the population in endemic and non-endemic areas'.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 3

Albert Schriefer

26 Sep 2022

Determinants of Anthroponotic Cutaneous Leishmaniasis by Case-Control Study in Morocco

PONE-D-22-07886R3

Dear Dr. Boussa,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Albert Schriefer, M.D., Ph.D.

Section Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Albert Schriefer

5 Oct 2022

PONE-D-22-07886R3

DETERMINANTS OF ANTHROPONOTIC CUTANEOUS LEISHMANIASIS BY CASE-CONTROL STUDY IN MOROCCO

Dear Dr. Boussaa:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Albert Schriefer

Section Editor

PLOS ONE


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES